We are live on ! Find out more
FP

Flagship Pioneering Portfolio holdings

AUM $1.16B
1-Year Est. Return 67.93%
This Fund
S&P 500
This Quarter Est. Return
-10.27%
1 Year Est. Return
+67.93%
3 Year Est. Return
-39.17%
5 Year Est. Return
-45.89%
10 Year Est. Return
–
AUM
$1.83B
AUM Growth
-$482M
Cap. Flow
-$53.4M
Cap. Flow %
-2.92%
Top 10 Hldgs %
100%
Holding
10
New
–
Increased
–
Reduced
1
Closed
1

Top Buys

No buys this quarter

Top Sells

Rank Stock Value
1
QTRX icon
Quanterix
QTRX
+$50.9M
2
SYRS
Syros Pharmaceuticals, Inc. Common Stock
SYRS
+$2.51M

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MRNA icon
1
Moderna
MRNA
$21.5B
$936M 51.21%
58,807,379
– –
RUBY
2
DELISTED
Rubius Therapeutics, Inc
RUBY
$301M 16.45%
38,296,526
– –
KLDO
3
DELISTED
Kaleido Biosciences, Inc. Common Stock
KLDO
$131M 7.15%
17,360,710
– –
DNLI icon
4
Denali Therapeutics
DNLI
$3.67B
$123M 6.71%
8,005,747
– –
EVLO
5
DELISTED
Evelo Biosciences, Inc. Common Stock
EVLO
$111M 6.08%
911,670
– –
MCRB icon
6
Seres Therapeutics
MCRB
$48.1M
$86.5M 4.73%
1,078,588
– –
TMDX icon
7
Transmedics
TMDX
$2.5B
$60.1M 3.29%
2,530,275
– –
AXLA
8
DELISTED
Axcella Health Inc. Common Stock
AXLA
$49.5M 2.71%
349,937
– –
SYRS
9
DELISTED
Syros Pharmaceuticals, Inc. Common Stock
SYRS
$30.5M 1.67%
293,849
-26,595
-8% -$2.51M
QTRX icon
10
Quanterix
QTRX
$173M
– –
-1,825,412
Closed -$50.9M

Similar funds

AC
AltraVue Capital Bellevue, Washington $1.16B AUM 46.45% 1-Year Est. Return
BI
Bramshill Investments Naples, Florida $1.16B AUM 0.86% 1-Year Est. Return
SCP
Sandhill Capital Partners Buffalo, New York $1.16B AUM 12.37% 1-Year Est. Return
SFG
SNS Financial Group Minneapolis, Minnesota $1.16B AUM 13.88% 1-Year Est. Return
GAB
German American Bancorp Jasper, Indiana $1.16B AUM 25.7% 1-Year Est. Return
AMI
Amica Mutual Insurance Providence, Rhode Island $1.16B AUM 21.34% 1-Year Est. Return
FFP
FourThought Financial Partners Venice, Florida $1.16B AUM 24.95% 1-Year Est. Return
MI
MMCAP International Grand Cayman, Cayman Islands $1.16B AUM 77.9% 1-Year Est. Return

Flagship Pioneering's Q3 2019 Portfolio in Review

As of Q3 2019, Flagship Pioneering held 10 positions worth $1.83B, down 21% from $2.31B the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Flagship Pioneering's Q3 2019 filing shows 1 reduced and 1 closed positions. The largest sale was Quanterix, an estimated $50.9M.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

  • Flagship Pioneering's biggest Q3 2019 reduction was Syros Pharmaceuticals, Inc. Common Stock, cutting an estimated $2.51M.
  • Flagship Pioneering fully exited Quanterix in Q3 2019, selling an estimated $50.9M.
  • Flagship Pioneering's ten largest holdings make up 100% of its $1.83B portfolio in Q3 2019.
  • Flagship Pioneering opened 0 new positions and closed 1 in Q3 2019.
  • Flagship Pioneering's portfolio value fell 21% quarter-over-quarter to $1.83B.

Based on Flagship Pioneering's 13F filing for Q3 2019, filed 14 Nov 2019.